238 related articles for article (PubMed ID: 11405075)
41. Expression and release of the latent transforming growth factor beta binding protein by hepatocytes from rat liver.
Roth S; Schurek J; Gressner AM
Hepatology; 1997 Jun; 25(6):1398-405. PubMed ID: 9185759
[TBL] [Abstract][Full Text] [Related]
42. Transforming growth factor beta 1 and its latent form binding protein-1 associate with elastic fibres in human dermis: accumulation in actinic damage and absence in anetoderma.
Karonen T; Jeskanen L; Keski-Oja J
Br J Dermatol; 1997 Jul; 137(1):51-8. PubMed ID: 9274625
[TBL] [Abstract][Full Text] [Related]
43. Latent transforming growth factor beta-binding proteins and fibulins compete for fibrillin-1 and exhibit exquisite specificities in binding sites.
Ono RN; Sengle G; Charbonneau NL; Carlberg V; Bächinger HP; Sasaki T; Lee-Arteaga S; Zilberberg L; Rifkin DB; Ramirez F; Chu ML; Sakai LY
J Biol Chem; 2009 Jun; 284(25):16872-16881. PubMed ID: 19349279
[TBL] [Abstract][Full Text] [Related]
44. Amino acid requirements for formation of the TGF-beta-latent TGF-beta binding protein complexes.
Chen Y; Ali T; Todorovic V; O'leary JM; Kristina Downing A; Rifkin DB
J Mol Biol; 2005 Jan; 345(1):175-86. PubMed ID: 15567420
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical localization of latent transforming growth factor-beta binding protein in IgA nephropathy.
Wada T; Hamakawa S; Hori Y; Kaname S; Shimizu S; Kurokawa K; Katoh T
Kidney Int Suppl; 1997 Dec; 63():S182-4. PubMed ID: 9407453
[TBL] [Abstract][Full Text] [Related]
46. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development.
Picht G; Welge-Luessen U; Grehn F; Lütjen-Drecoll E
Graefes Arch Clin Exp Ophthalmol; 2001 Mar; 239(3):199-207. PubMed ID: 11405069
[TBL] [Abstract][Full Text] [Related]
47. Expressional alterations of fibrillin-1 during wound healing of human dental pulp.
Yoshiba N; Yoshiba K; Ohkura N; Hosoya A; Shigetani Y; Yamanaka Y; Izumi N; Nakamura H; Okiji T
J Endod; 2012 Feb; 38(2):177-84. PubMed ID: 22244632
[TBL] [Abstract][Full Text] [Related]
48. Effects of mammalian target of rapamycin inhibitors on fibrosis after trabeculectomy.
Igarashi N; Honjo M; Aihara M
Exp Eye Res; 2021 Feb; 203():108421. PubMed ID: 33359326
[TBL] [Abstract][Full Text] [Related]
49. The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix.
Gregory KE; Ono RN; Charbonneau NL; Kuo CL; Keene DR; Bächinger HP; Sakai LY
J Biol Chem; 2005 Jul; 280(30):27970-80. PubMed ID: 15929982
[TBL] [Abstract][Full Text] [Related]
50. Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture.
Breitkopf K; Lahme B; Tag CG; Gressner AM
Hepatology; 2001 Feb; 33(2):387-96. PubMed ID: 11172340
[TBL] [Abstract][Full Text] [Related]
51. Regulation of cell surface tissue transglutaminase: effects on matrix storage of latent transforming growth factor-beta binding protein-1.
Verderio E; Gaudry C; Gross S; Smith C; Downes S; Griffin M
J Histochem Cytochem; 1999 Nov; 47(11):1417-32. PubMed ID: 10544215
[TBL] [Abstract][Full Text] [Related]
52. Liver portal fibrosis in dioxin receptor-null mice that overexpress the latent transforming growth factor-beta-binding protein-1.
Corchero J; Martín-Partido G; Dallas SL; Fernández-Salguero PM
Int J Exp Pathol; 2004 Oct; 85(5):295-302. PubMed ID: 15379962
[TBL] [Abstract][Full Text] [Related]
53. Immunoelectron microscopic localization of transforming growth factor beta 1 and latent transforming growth factor beta 1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells.
Mizoi T; Ohtani H; Miyazono K; Miyazawa M; Matsuno S; Nagura H
Cancer Res; 1993 Jan; 53(1):183-90. PubMed ID: 8416744
[TBL] [Abstract][Full Text] [Related]
54. LTBP-1 blockade in dioxin receptor-null mouse embryo fibroblasts decreases TGF-beta activity: Role of extracellular proteases plasmin and elastase.
Gomez-Duran A; Mulero-Navarro S; Chang X; Fernandez-Salguero PM
J Cell Biochem; 2006 Feb; 97(2):380-92. PubMed ID: 16187295
[TBL] [Abstract][Full Text] [Related]
55. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
Tritschler I; Gramatzki D; Capper D; Mittelbronn M; Meyermann R; Saharinen J; Wick W; Keski-Oja J; Weller M
Int J Cancer; 2009 Aug; 125(3):530-40. PubMed ID: 19431147
[TBL] [Abstract][Full Text] [Related]
56. Fibronectin and heparin binding domains of latent TGF-beta binding protein (LTBP)-4 mediate matrix targeting and cell adhesion.
Kantola AK; Keski-Oja J; Koli K
Exp Cell Res; 2008 Aug; 314(13):2488-500. PubMed ID: 18585707
[TBL] [Abstract][Full Text] [Related]
57. Co-localization of LTBP-2 with FGF-2 in fibrotic human keloid and hypertrophic scar.
Sideek MA; Teia A; Kopecki Z; Cowin AJ; Gibson MA
J Mol Histol; 2016 Feb; 47(1):35-45. PubMed ID: 26644005
[TBL] [Abstract][Full Text] [Related]
58. Analysis of the expression pattern of the latent transforming growth factor beta binding protein isoforms in normal and diseased human liver reveals a new splice variant missing the proteinase-sensitive hinge region.
Michel K; Roth S; Trautwein C; Gong W; Flemming P; Gressner AM
Hepatology; 1998 Jun; 27(6):1592-9. PubMed ID: 9620332
[TBL] [Abstract][Full Text] [Related]
59. Identification and characterization of LTBP-2, a novel latent transforming growth factor-beta-binding protein.
Morén A; Olofsson A; Stenman G; Sahlin P; Kanzaki T; Claesson-Welsh L; ten Dijke P; Miyazono K; Heldin CH
J Biol Chem; 1994 Dec; 269(51):32469-78. PubMed ID: 7798248
[TBL] [Abstract][Full Text] [Related]
60. Recombinant latent transforming growth factor beta-binding protein 2 assembles to fibroblast extracellular matrix and is susceptible to proteolytic processing and release.
Hyytiäinen M; Taipale J; Heldin CH; Keski-Oja J
J Biol Chem; 1998 Aug; 273(32):20669-76. PubMed ID: 9685426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
